Factor-VIII, in Visit Clinic

Factor VIII is a large glycoprotein clotting cofactor composed of six domains (A1–A2–B–A3–C1–C2). It is synthesized as a single-chain polypeptide that is glycosylated and processed into a heterodimer of heavy (A1–A2) and light (A3–C1–C2) chains. Thrombin activation removes the B domain to form active factor VIIIa, which circulates bound to von Willebrand factor.

Factor VIII and von Willebrand factor (vWF) are related but not the same. vWF is a large adhesive protein that helps platelets stick at injury sites and carries/stabilizes Factor VIII in the blood. Factor VIII is a separate clotting protein; deficiency causes hemophilia A. vWF deficiency can also lower Factor VIII levels and cause bleeding, but they are distinct molecules.

High factor VIII means elevated levels of a clotting protein that increase risk of blood clots (DVT/PE). Causes include inflammation, infection, pregnancy, liver disease, obesity, or hereditary tendency. Factor VIII is an acute‑phase reactant, so levels may be temporarily high. Doctors often repeat testing when you're well, investigate underlying causes, and consider anticoagulation if clot risk or previous thrombosis is present.

The normal range for factor VIII activity is approximately 50–150% of normal (0.5–1.5 IU/mL or 50–150 IU/dL). Levels below 50% indicate deficiency (mild, moderate, or severe depending on degree). Elevated levels above this range can occur transiently with inflammation, pregnancy, or oral contraceptive use. Clinical interpretation should consider symptoms and repeat testing.

When factor VIII is low, blood cannot clot properly, causing hemophilia A. People experience easy bruising, prolonged bleeding from cuts or after surgery or dental work, and recurrent joint and muscle bleeds that can cause chronic pain and damage. Severe deficiency raises risk of spontaneous internal bleeding. Diagnosis is by blood tests; treatment includes factor VIII replacement, medications that boost clotting, and preventive care.

Another name for factor VIII is antihemophilic factor (AHF), often called antihemophilic factor A. It is a blood‑clotting protein essential for the intrinsic coagulation pathway. Deficiency or dysfunction of factor VIII causes hemophilia A, a bleeding disorder marked by prolonged bleeding and easy bruising. Factor VIII circulates bound to von Willebrand factor, which stabilizes and protects it.